A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication.
For adoptive cell transfer (ACT) immunotherapy of tumor-reactive T cells, an effective therapeutic outcome depends upon cell dose, cell expansion in vivo through a minimally differentiated phenotype, long term persistence, and strong cytolytic effector function. An incomplete understanding of the bi...
Main Authors: | Jing Zhou, Michael T Bethune, Natalia Malkova, Alexander M Sutherland, Begonya Comin-Anduix, Yapeng Su, David Baltimore, Antoni Ribas, James R Heath |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0191634 |
Similar Items
-
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
by: Comin-Anduix Begonya, et al.
Published: (2009-05-01) -
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
by: Giulia Parisi, et al.
Published: (2020-01-01) -
Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance.
by: Yapeng Su, et al.
Published: (2019-06-01) -
Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
by: Rong Du, et al.
Published: (2021-03-01) -
Ultrasound-assisted cell eradication
by: Smalberger, Charl
Published: (2021)